A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

Conditions: Hypoalbuminemia; Hepatic Cirrhosis Interventions: Drug: OsrHSA; Drug: Plasbumin ®-20 Sponsors: Healthgen Biotechnology Corp. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials